STRATEC SE (SBS.DE) Stock Price & Overview

FRA:SBS • DE000STRA555

Current stock price

18.84 EUR
-0.06 (-0.32%)
Last:

The current stock price of SBS.DE is 18.84 EUR. Today SBS.DE is down by -0.32%. In the past month the price decreased by -5.42%. In the past year, price decreased by -32.95%.

SBS.DE Key Statistics

52-Week Range18.3 - 33.1
Current SBS.DE stock price positioned within its 52-week range.
1-Month Range18.3 - 21.75
Current SBS.DE stock price positioned within its 1-month range.
Market Cap
229.094M
P/E
14.27
Fwd P/E
9.98
EPS (TTM)
1.32
Dividend Yield
3.11%

SBS.DE Stock Performance

Today
-0.32%
1 Week
-3.38%
1 Month
-5.42%
3 Months
-14.17%
Longer-term
6 Months -31.49%
1 Year -32.95%
2 Years -53.13%
3 Years -69.90%
5 Years -83.65%
10 Years -55.79%

SBS.DE Stock Chart

STRATEC SE / SBS Daily stock chart

SBS.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SBS.DE. When comparing the yearly performance of all stocks, SBS.DE is a bad performer in the overall market: 91.82% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SBS.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to SBS.DE. SBS.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SBS.DE Earnings

Next Earnings DateN/A
Last Earnings DateNov 7, 2025
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

SBS.DE Forecast & Estimates

11 analysts have analysed SBS.DE and the average price target is 34.95 EUR. This implies a price increase of 85.5% is expected in the next year compared to the current price of 18.84.

For the next year, analysts expect an EPS growth of -11.28% and a revenue growth 0.4% for SBS.DE


Analysts
Analysts80
Price Target34.95 (85.51%)
EPS Next Y-11.28%
Revenue Next Year0.4%

SBS.DE Groups

Sector & Classification

Index Membership

SBS.DE Financial Highlights

Over the last trailing twelve months SBS.DE reported a non-GAAP Earnings per Share(EPS) of 1.32. The EPS increased by 4.26% compared to the year before.


Income Statements
Revenue(TTM)257.62M
Net Income(TTM)16.02M
Industry RankSector Rank
PM (TTM) 6.22%
ROA 3.72%
ROE 6.67%
Debt/Equity 0.49
Chartmill High Growth Momentum
EPS Q2Q%173.23%
Sales Q2Q%-0.4%
EPS 1Y (TTM)4.26%
Revenue 1Y (TTM)-4.73%

SBS.DE Ownership

Ownership
Inst Owners39.05%
Shares12.16M
Float6.40M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

SBS.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
2M6 MEDTRONIC PLC14.3997.986B
SHL SIEMENS HEALTHINEERS AG14.8644.026B
PHI1 KONINKLIJKE PHILIPS NV15.9623.794B
PHIA KONINKLIJKE PHILIPS NV15.9623.707B
BIM BIOMERIEUX19.4911.167B
DIA DIASORIN SPA15.633.624B
OBCK OTTOBOCK SE & CO KGAA17.773.423B
AFX CARL ZEISS MEDITEC AG - BR11.52.111B
DRW3 DRAEGERWERK AG - PREF10.891.601B
DRW8 DRAEGERWERK AG8.671.287B
ELN EL.EN. SPA20.391.008B
EUZ ECKERT & ZIEGLER SE17.54943.272M
GVS GVS SPA12.15669.697M

About SBS.DE

Company Profile

SBS logo image STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,450 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.

Company Info

IPO: 1998-08-25

STRATEC SE

Gewerbestr. 37

BIRKENFELD BADEN-WUERTTEMBERG DE

Employees: 1462

SBS Company Website

SBS Investor Relations

Phone: 49708279160

STRATEC SE / SBS.DE FAQ

Can you describe the business of STRATEC SE?

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,450 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.


What is the current price of SBS stock?

The current stock price of SBS.DE is 18.84 EUR. The price decreased by -0.32% in the last trading session.


Does STRATEC SE pay dividends?

STRATEC SE (SBS.DE) has a dividend yield of 3.11%. The yearly dividend amount is currently 0.55.


How is the ChartMill rating for STRATEC SE?

SBS.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for SBS.DE stock?

11 analysts have analysed SBS.DE and the average price target is 34.95 EUR. This implies a price increase of 85.5% is expected in the next year compared to the current price of 18.84.


What is the Price/Earnings (PE) ratio of STRATEC SE (SBS.DE)?

The PE ratio for STRATEC SE (SBS.DE) is 14.27. This is based on the reported non-GAAP earnings per share of 1.32 and the current share price of 18.84 EUR.


Can you provide the number of employees for STRATEC SE?

STRATEC SE (SBS.DE) currently has 1462 employees.